article thumbnail

The Society of Thoracic Surgeons Launches New Valve Surgery Risk Calculators

DAIC

SAVR after TAVR Surgical aortic valve replacement after prior TAVR is the fastest-growing cardiac surgery procedure in the U.S. The majority require explant of the TAVR device and SAVR, which significantly increases the risk of operative mortality and stroke. and 3.8%, respectively.

TAVR 111
article thumbnail

New Study Finds Mechanical Valves Offer Superior Long-Term Survival for Aortic Valve Replacement Patients Aged 60 and Younger

Society of Thoracic Surgeons - Congenital

The findings are particularly relevant considering the increasing adoption of bioprosthetic surgical valves in many patients and the recent trend of bioprosthetic transcatheter aortic valve replacement (TAVR) in younger populations without clear evidence.

article thumbnail

SAVR After TAVR Risk Calculator

Society of Thoracic Surgeons - Congenital

Resource SAVR After TAVR Risk Calculator kchalko Fri, 04/12/2024 - 13:53 SAVR after previous TAVR is the fastest-growing cardiac surgery procedure in the U.S. The majority of patients require explant of their TAVR device and SAVR with significantly increased risk of operative mortality and stroke.

TAVR 52
article thumbnail

Evolving Trends in TAVR

Society of Thoracic Surgeons - Congenital

Video Evolving Trends in TAVR nboden Wed, 07/18/2018 - 09:06 The volumes of two aortic valve replacements (AVR) procedures have changed dramatically over the past few years, with more transcatheter procedures now being performed than open surgical procedures. Mack, MD (The Heart Hospital Baylor Plano), John V.

TAVR 52
article thumbnail

CT Surgeons Present Study Findings on SAVR vs. TAVR

Society of Thoracic Surgeons - Congenital

On day one of STS 2024, meeting goers attended numerous sessions that explored the growing debate between SAVR and TAVR as treatment options,

TAVR 52
article thumbnail

Global Differences in Managing Patients with Aortic Valve Disease

Society of Thoracic Surgeons - Congenital

The industry is producing enormously expensive catheter-based valve substitutes for these procedures such as transcatheter aortic valve replacement (TAVR). The medical community wanted to jump on the Bandwagon and aggressively market TAVR for patients. However, a vast need remains for more affordable and conservative treatment options.

article thumbnail

Comparing TAVR and SAVR in Medicare Beneficiaries with Aortic Stenosis and Coronary Artery Disease

Society of Thoracic Surgeons - Congenital

During the Top Adult Cardiac Surgery Abstracts session on Sunday, Jan. Hunter Mehaffey, MD, a cardiothoracic surgeon from West Virginia University, will examine results comparing two treatment options Transcatheter vs. Surgical Aortic Valve Replacement in Medicare Beneficiaries with Aortic Stenosis and Significant Coronary Disease.